{"api_version": 1, "episode_id": "ep_a16z_154062ed1aa3", "title": "a16z Podcast: The Genetics Of Drug Delivery", "podcast": "The a16z Show", "podcast_slug": "a16z", "category": "science", "publish_date": "2017-03-07T00:31:50+00:00", "audio_url": "https://mgln.ai/e/1344/afp-848985-injected.calisto.simplecastaudio.com/3f86df7b-51c6-4101-88a2-550dba782de8/episodes/ab608ca8-319d-40a8-a82e-5309dff0d0d0/audio/128/default.mp3?aid=rss_feed&awCollectionId=3f86df7b-51c6-4101-88a2-550dba782de8&awEpisodeId=ab608ca8-319d-40a8-a82e-5309dff0d0d0&feed=JGE3yC0V", "source_link": "https://a16z.simplecast.com/episodes/a16z-podcast-the-genetics-of-drug-delivery-Bb5AkZAS", "cover_image_url": "https://image.simplecastcdn.com/images/0d97354a-306b-45f5-bf26-a8d81eef47ec/ed2664df-9371-438e-8baf-dd2ee0fdde87/3000x3000/thea16zshow-podcastcoverart-3000x3000.jpg?aid=rss_feed", "summary": "Russ Altman presents the Pharmacogenomics Knowledge Base (PharmGKB), a 16-year effort to map how human genetic variation affects drug response, using multi-scale data integration from molecular interactions to electronic health records. He demonstrates how combining FDA adverse event reports, EHRs, and mouse models revealed unlisted drug interactions, such as paroxetine and pravastatin causing hyperglycemia. The framework enables drug repurposing, side effect prediction, and precision prescribing based on genetic profiles.", "key_takeaways": ["Genetic variation significantly impacts drug metabolism\u2014e.g., 7% of Europeans can't activate codeine due to a liver enzyme deficiency.", "Combining data across biological scales (molecular, cellular, organismal, population) increases confidence in detecting real drug effects and interactions.", "Unapproved drug combinations like paroxetine and pravastatin can cause significant side effects (e.g., hyperglycemia) undetected in traditional trials."], "best_for": ["biomedical researchers", "pharmaceutical developers", "precision medicine clinicians"], "why_listen": "You get a concrete, multi-scale data framework for predicting drug effects, interactions, and repurposing opportunities grounded in real-world evidence and genetics.", "verdict": "must_listen", "guests": [], "entities": {}, "quotes": [], "chapters": [], "overall_score": 90.0, "score_breakdown": {"clarity": 92.0, "originality": 87.0, "actionability": 88.0, "technical_depth": 90.0, "information_density": 94.0}, "score_evidence": {"clarity": "the themes in our lab... are the ones that integrate these scales, because a signal that you get at the molecular level and at the electronic medical record level gives you oodles more confidence.", "originality": "we took that information and went to search logs... we showed a remarkable increase in the occurrence of words associated with hyperglycemia when they had also typed in the two drugs together.", "actionability": "we were able to find tens or hundreds of extra side effects per drug with very high confidence from looking at a combination of FDA records and electronic medical records.", "technical_depth": "there's an enzyme in your liver that transforms it into morphine... 7% of people of European descent don't have a version... codeine is a placebo for them.", "information_density": "we looked at population data, electronic medical record data, and organism-level data in mice... combined these all and we found a very strong signal associated with the use of the two drugs together."}, "score_reasoning": {}, "scoring_confidence": 0.98, "transcript_available": true, "transcript_chars": 15828, "transcript_provider": "groq"}